Angiodynamics (ANGO) Total Liabilities (2016 - 2025)
Angiodynamics (ANGO) has disclosed Total Liabilities for 15 consecutive years, with $93.3 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Total Liabilities rose 149.98% year-over-year to $93.3 million, compared with a TTM value of $93.3 million through Nov 2025, up 149.98%, and an annual FY2025 reading of $97.2 million, down 13.3% over the prior year.
- Total Liabilities was $93.3 million for Q4 2025 at Angiodynamics, up from $86.8 million in the prior quarter.
- Across five years, Total Liabilities topped out at $154.3 million in Q2 2023 and bottomed at -$218.7 million in Q1 2024.
- Average Total Liabilities over 5 years is $68.9 million, with a median of $112.8 million recorded in 2022.
- The sharpest move saw Total Liabilities plummeted 397.42% in 2024, then surged 149.98% in 2025.
- Year by year, Total Liabilities stood at $121.7 million in 2021, then grew by 23.42% to $150.2 million in 2022, then plummeted by 34.53% to $98.4 million in 2023, then crashed by 289.86% to -$186.8 million in 2024, then skyrocketed by 149.98% to $93.3 million in 2025.
- Business Quant data shows Total Liabilities for ANGO at $93.3 million in Q4 2025, $86.8 million in Q3 2025, and $97.2 million in Q2 2025.